Description

Book Synopsis

The field of immuno-oncology continues to rapidly evolve as new insights to fight and treat cancer emerge. The fourth edition of Immunotherapy provides the most current overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. While immunotherapy has revolutionized the treatment landscape of several solid malignancies, several challenges still exist.

Only a subset of patients derive clinical benefits; some do not respond at all, and others respond initially, only for their disease to progress later. Because these drugs can activate a broad range of immune cells, patients suffer from a unique set of side effects known as immune-related adverse events. As more immunotherapeutic agents are used in the clinic, it is important to provide updates about current and ongoing developments in the field to further research efforts and inform treatment decisions.

The fourth edition will have a new focus on strategies to overcome the challenges associated with immunotherapy. Chapters will discuss topics such as biomarkers of response, resistance mechanisms, role of imaging in predicting immune-related adverse events, and management of immune-related adverse events. Written by leading experts conducting cutting-edge research, readers will gain up-to-date knowledge on the current state and future of immunotherapy.



Table of Contents

Table of contents


1. Immune System in Action

2. Resistance to Immunotherapy: Mechanisms and Means for Overcoming

3. Immunotherapy for Melanoma


4. Immunotherapy in Lung Cancer: Are the promises of long-term benefit finally met?


5. Landscape of Immunotherapy in Genitourinary Malignancies


6. Immuno-oncology for Gynecologic Malignancies


7. Immunotherapy for Neuro-oncology


8. Immunotherapy in Gastrointestinal Malignancies


9. An update on immune based therapies in acute myeloid leukemia: 2021 and beyond!


10. CAR T-cells


11. Skin Reactions to Immune Checkpoint Inhibitors

12. Immunotherapy Mediated luminal Gastrointestinal toxicities


13. Hepatobiliary and Pancreatic Adverse Events


14. Pulmonary toxicities of immunotherapy


15. Immune checkpoint inhibitors (ICIs) related cardiotoxicity


16. Renal Toxicity


17. Immune-Related Oral, Otologic and Ocular Adverse Events


18. Neurologic Toxicities of Immunotherapy


19. Cancer Imaging in Immunotherapy


Immunotherapy

    Product form

    A Hardback by Aung Naing, Joud Hajjar

    £999.99

    Includes FREE delivery

    Out of stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Immunotherapy by Aung Naing

      Book details

      Publisher Springer Nature
      Published 21 December 2021
      ISBN-13 9783030793074
      978-3030793074
      ISBN-10 3030793079
      Also in:
      Oncology

      Description

      Book Synopsis

      The field of immuno-oncology continues to rapidly evolve as new insights to fight and treat cancer emerge. The fourth edition of Immunotherapy provides the most current overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. While immunotherapy has revolutionized the treatment landscape of several solid malignancies, several challenges still exist.

      Only a subset of patients derive clinical benefits; some do not respond at all, and others respond initially, only for their disease to progress later. Because these drugs can activate a broad range of immune cells, patients suffer from a unique set of side effects known as immune-related adverse events. As more immunotherapeutic agents are used in the clinic, it is important to provide updates about current and ongoing developments in the field to further research efforts and inform treatment decisions.

      The fourth edition will have a new focus on strategies to overcome the challenges associated with immunotherapy. Chapters will discuss topics such as biomarkers of response, resistance mechanisms, role of imaging in predicting immune-related adverse events, and management of immune-related adverse events. Written by leading experts conducting cutting-edge research, readers will gain up-to-date knowledge on the current state and future of immunotherapy.



      Table of Contents

      Table of contents


      1. Immune System in Action

      2. Resistance to Immunotherapy: Mechanisms and Means for Overcoming

      3. Immunotherapy for Melanoma


      4. Immunotherapy in Lung Cancer: Are the promises of long-term benefit finally met?


      5. Landscape of Immunotherapy in Genitourinary Malignancies


      6. Immuno-oncology for Gynecologic Malignancies


      7. Immunotherapy for Neuro-oncology


      8. Immunotherapy in Gastrointestinal Malignancies


      9. An update on immune based therapies in acute myeloid leukemia: 2021 and beyond!


      10. CAR T-cells


      11. Skin Reactions to Immune Checkpoint Inhibitors

      12. Immunotherapy Mediated luminal Gastrointestinal toxicities


      13. Hepatobiliary and Pancreatic Adverse Events


      14. Pulmonary toxicities of immunotherapy


      15. Immune checkpoint inhibitors (ICIs) related cardiotoxicity


      16. Renal Toxicity


      17. Immune-Related Oral, Otologic and Ocular Adverse Events


      18. Neurologic Toxicities of Immunotherapy


      19. Cancer Imaging in Immunotherapy


      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account